BTIG initiated coverage of NRx Pharmaceuticals (NRXP) with a Buy rating and $18 price target NRx Pharmaceuticals is working broadly in ...

Fintel reports that on March 31, 2025, BTIG upgraded their outlook for Progyny (NasdaqGS:PGNY) from Neutral to Buy. Analyst ...

BTIG upgraded Progyny (PGNY) to Buy from Neutral with a $28 price target The firm says the company’s demand is coming back up, the stock’s ...

CrowdStrike (CRWD) was upgraded from Neutral to Buy by BTIG, and maintains a $431 price target on the stock. Market Domination hosts Julie Hyman and Josh Lipton break down BTIG's reasons for the ...

BTIG Research assumed coverage on shares of Super Group (NYSE:SGHC – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The firm issued a buy rating and a $9.00 ...

Investing.com -- BTIG downgraded Ally Financial (NYSE:ALLY) Inc to Sell from Neutral with a $30 target saying a challenging macroeconomic condition and increased competition in the auto lending ...

Shares of CrowdStrike ( CRWD 3.34%) surged higher on Monday. The company's stock had gained 3.7% as of 10:50 a.m. ET but had ...

Friday’s stock market slide will likely cement the S&P 500 and Nasdaq Composite’s seventh weekly decline in nine weeks. The S ...

BTIG analysts highlighted a historical trend suggesting a potential rebound for the S&P 500 (SPX) in April following a ...

Lululemon Athletica (NASDAQ:LULU – Free Report) had its price objective decreased by BTIG Research from $470.00 to $420.00 in ...